BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32963063)

  • 1. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial longitudinal follow-up protocol.
    Mazza D; Amos N; Watson CJ; McGeechan K; Haas M; Peipert JF; Lucke J; Taft A; McNamee K; Black KI
    BMJ Open; 2020 Sep; 10(9):e035895. PubMed ID: 32963063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
    Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
    BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.
    Mazza D; Watson CJ; Taft A; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Black KI
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S921.e1-S921.e13. PubMed ID: 31837291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving rural and regional access to long-acting reversible contraception and medical abortion through nurse-led models of care, task-sharing and telehealth (ORIENT): a protocol for a stepped-wedge pragmatic cluster-randomised controlled trial in Australian general practice.
    Mazza D; Shankar M; Botfield JR; Moulton JE; Chakraborty SP; Black K; Tomnay J; Bateson D; Church J; Laba TL; Kasza J; Norman WV
    BMJ Open; 2023 Mar; 13(3):e065137. PubMed ID: 36948556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a complex intervention in general practice to increase uptake of long-acting reversible contraceptives in Australia.
    Lewandowska M; De Abreu Lourenco R; Haas M; Watson CJ; Black KI; Taft A; Lucke J; McGeechan K; McNamee K; Peipert JF; Mazza D
    Aust Health Rev; 2021 Dec; 45(6):728-734. PubMed ID: 34903325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustainable and effective methods to increase long-acting reversible contraception uptake from the ACCORd general practice trial.
    Taft A; Watson CJ; McCarthy E; Black KI; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Mazza D
    Aust N Z J Public Health; 2022 Aug; 46(4):540-544. PubMed ID: 35557481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interactive website to aid young women's choice of contraception: feasibility and efficacy RCT.
    Stephenson J; Bailey JV; Blandford A; Brima N; Copas A; D'Souza P; Gubijev A; Hunter R; Shawe J; Rait G; Oliver S
    Health Technol Assess; 2020 Nov; 24(56):1-44. PubMed ID: 33164729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the availability of long-acting reversible contraception and medical abortion in primary care: the Australian Contraception and Abortion Primary Care Practitioner Support Network (AusCAPPS) cohort study protocol.
    Mazza D; James S; Black K; Taft A; Bateson D; McGeechan K; Norman WV
    BMJ Open; 2022 Dec; 12(12):e065583. PubMed ID: 36521891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current contraceptive use in women with a history of unintended pregnancies: Insights from the Australian Contraceptive ChOice pRoject (ACCORd) trial.
    Subasinghe AK; Watson CJ; Black KI; Taft A; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Mazza D
    Aust J Gen Pract; 2021 Jun; 50(6):422-425. PubMed ID: 34059848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's satisfaction with and ongoing use of hormonal long-acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd).
    Black KI; McGeechan K; Watson CJ; Lucke J; Taft A; McNamee K; Haas M; Peipert JF; Mazza D
    Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):448-453. PubMed ID: 33599984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and feasibility of a planned preconception weight loss intervention in women with long-acting reversible contraception: the Plan-it mixed-methods study.
    Channon S; Coulman E; Cannings-John R; Henley J; Lau M; Lugg-Widger F; Strange H; Davies F; Sanders J; Scherf C; Couzens Z; Morantz L
    Health Technol Assess; 2023 Jan; 27(1):1-224. PubMed ID: 36688498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways to IUD and implant insertion in general practice: a secondary analysis of the ACCORd study.
    Mazza D; Watson CJ; Taft A; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Black KI
    Aust J Prim Health; 2023 Jul; 29(3):222-228. PubMed ID: 37121607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using automated voice messages linked to telephone counselling to increase post-menstrual regulation contraceptive uptake and continuation in Bangladesh: study protocol for a randomised controlled trial.
    Reiss K; Andersen K; Barnard S; Ngo TD; Biswas K; Smith C; Carpenter J; Church K; Nuremowla S; Pearson E
    BMC Public Health; 2017 Oct; 17(1):769. PubMed ID: 28974209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do women need to know about long-acting reversible contraception? Perspectives of women from culturally and linguistically diverse backgrounds.
    Liu R; Mazza D; Li CK; Subasinghe AK
    Health Promot J Austr; 2024 Apr; 35(2):276-284. PubMed ID: 37161644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial).
    Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
    BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding community pharmacists' scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE).
    Mazza D; Assifi AR; Hussainy SY; Bateson D; Johnston S; Tomnay J; Kasza J; Church J; Grzeskowiak LE; Nissen L; Cameron ST
    BMJ Open; 2023 Aug; 13(8):e073154. PubMed ID: 37652588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.